SCIEX Supports Cancer Survival Research Through Donation to World Cancer Research Fund

SCIEX,
a global leader in life science analytical technologies, has donated
US$17,500 (£12,613.21) to World
Cancer Research Fund (WCRF). A donation of US$11,000 was made as the
result of 98% participation in the annual SCIEX employee engagement
survey, where SCIEX committed to making a donation to this very
important cause based on the number of survey responses collected. An
additional US$6,500 was donated by Danaher Foundation, the parent
company of SCIEX. The contribution will help to fund urgently-needed
research investigating the relationships between food, nutrition
(including body composition) and physical activity with cancer prognosis
and outcome in cancer survivors. Since 2015, SCIEX has donated more than
US$30,000 (£24,068.82 GBP) to the charity.

Being overweight or obese increases the risk of 12 cancers, including
breast and bowel cancer.1 Carrying excess body fat can lead
to changes within the body, such as elevated hormone levels, insulin
resistance and chronic inflammation, which in turn creates an internal
environment conducive to cancer development and progression.1
It has been estimated that around 694,000 cancer cases each year could
be prevented in the US, and 144,000 in the UK, by reducing exposure to
cancer risk factors including those related to diet, weight and physical
inactivity.2

Although increasing numbers of people are affected by cancer, the
current advice on what dietary and physical activity patterns could
improve their quality of life is not based on strong evidence.1
WCRF is funding vital research into understanding how diet, nutrition
and physical activity affect response to treatment, improve quality of
life and influence cancer survival for these people.

The most recent donation from SCIEX will help WCRF to fund this kind of
scientific research. For example, one important project, funded by WCRF,
aims to better understand how body composition affects cancer survival,
an area fraught with methodological difficulties. The research,3
which is being conducted by a group at the University of Manchester and
led by Professor Andrew Renehan, is investigating whether elevated body
mass index (BMI), measured at or after diagnosis in patients with bowel
or womb cancer, is associated with reduced overall survival compared
with a “healthy” BMI.

“SCIEX is very proud to support organizations that promote healthcare
research and discovery, community engagement and efforts toward
innovative approaches to improve quality of life around the world,” says
Inese Lowenstein, President, SCIEX. “The SCIEX vision of placing
the power of life-changing answers into the hands of those who care,
everywhere aligns well with WCRF’s focus around empowering the public
and healthcare providers with information that could ultimately save
lives.”

Gerard Cousins, Director of Fundraising for WCRF UK says: “WCRF is proud
to have been working with SCIEX, an organization that shares our aim of
empowering people to make healthier lifestyle choices, since 2015. SCIEX
fundraising has helped to fund much-needed research into cancer
prevention, which has been reflected in our latest report Diet,
Nutrition, Physical Activity and Cancer: a Global Perspective, which
was launched in May.”

Many SCIEX customers worldwide work in cancer-related research, and the
charitable partnership with WCRF reflects the focus of SCIEX and its
customers who are making an impact in this area. With this donation,
SCIEX contributes to advancing science and the improvement of human
health and wellness not only by equipping healthcare professionals, but
also by supporting world-leading cancer scientists in the search for
better disease outcomes.

1. World Cancer Research Fund/American Institute for Cancer
Research. Continuous
Update Project Expert Report 2018. The cancer process.

2. WHO.
Cancer Prevention. World Health Organization. Accessed 15/06/2017;

3. The
impact of body mass index on cancer-related survival in
chemotherapy-naïve patients with non-metastatic colorectal and
endometrial cancer: a federation meta-analysis of trial data

About SCIEX

SCIEX helps to improve the world we live in by enabling scientists and
laboratory analysts to find answers to the complex analytical challenges
they face. The company’s global leadership and world-class service and
support in the capillary electrophoresis and liquid chromatography-mass
spectrometry industry have made it a trusted partner to thousands of the
scientists and lab analysts worldwide who are focused on basic research,
drug discovery and development, food and environmental testing,
forensics and clinical research.

With over 40 years of proven innovation, SCIEX excels by listening to
and understanding the ever-evolving needs of its customers to develop
reliable, sensitive and intuitive solutions that continue to redefine
what is achievable in routine and complex analysis. For more
information, please visit sciex.com.

SCIEX social: Twitter: @SCIEXnews,
LinkedIn
and Facebook.

For Research Use Only. Not for use in diagnostic procedures.
RUO-MKT-12-8013-A.

AB Sciex is operating as SCIEX.

©2018 AB Sciex. The trademarks mentioned herein are the property of the
AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used
under license.

About World Cancer Research Fund

World Cancer Research Fund is a leading authority on the links between
cancer prevention and survival and diet, weight and physical activity.
By funding and supporting research, developing policy guidance and
providing health information, we ensure that people can make informed
lifestyle choices to reduce their risk of developing a preventable
cancer. Our scientific research ensures that we will continue to have
the latest and most authoritative information at our fingertips, all
underpinned by independent expert advice.

For more information visit http://www.wcrf.org/ follow
us on Twitter at https://twitter.com/wcrfint,
read our blog at https://www.wcrf.org/int/blog
or visit our Facebook page at https://www.facebook.com/wcrfint.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180712005009/en/

Leave a Comment